214 research outputs found
Reminiscence of Rose McColl (Woolf)
Full text linkA typed biography of Rose McColl (Nee Woolf) by an unknown author. Rosa was born around 1904 in Glasgow, Scotland. She married John McCool and had one child, Ian McColl. She died March 4, 1958 at the age of 54 in Vancouver, BC. The collection also contains a photo of her
Where is student support most needed?
No full textBarrett and McColl raise the question posed in the title of their commentary to highlight the value of attending to interactions between students and their learning environment
Furthering the benefits of DBT for eating disorders: a lived experience correspondence on McColl et al.
No full textAbstract This Correspondence article provides a lived experience perspective on McColl et al.‘s study, which examines the use of Dialectical Behaviour Therapy for individuals with eating disorders. Drawing on experiences of DBT treatment for longstanding and severe anorexia, the author critically engages with the study’s findings, highlighting both the strengths and limitations of the treatment approach McColl et al. describe. While DBT has shown promise in addressing the emotional dysregulation and distress tolerance that underlie many eating disorder behaviours, the author emphasises the need for further adaptation to cater to the complexities of co-occurring physical, psychological, and neurodivergent conditions. The benefits of DBT for eating disorders are explored through personal reflections which emphasise the value and importance of skill-development, therapeutic validation, and motivation to build a “life worth living”. Additional, co-produced research is required to further develop the evidence for DBT-based approaches, with particular attention needed in addressing language, stigma, cultural biases, and exclusionary research and clinical practices. Writing from a UK context, the author ends by advocating for the reinstatement of DBT within national guidelines for eating disorder treatment, highlighting its transdiagnostic relevance and potential to provide comprehensive, holistic support for those with more complex presentations
Correction: Corrigendum: Adrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after stroke
No full textNature Communications 8 Article number: 15051 (2017); Published: 19 April 2017; Updated: 18 August 2017 The affiliation details for Barry W. McColl are incorrect in this Article. The correct affiliation details for this author are given below: The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian EH25 9RG, UK.</jats:p
Glucosamine for osteoarthritis of the knee
No full textGlucosamine is a normal constituent of the proteoglycans found in joint cartilage and synovial fluid. It has been recommended for many years by practitioners of complementary medicine for the treatment of osteoarthritis. Clinical trials have now shown that the use of oral glucosamine sulphate 1.5 g daily in patients with osteoarthritis of the knee results in a significant reduction in joint pain and an improvement in joint function. In addition, glucosamine appears to reduce the loss of cartilage in the knee joint over at least a three-year period, particularly in those with milder radiological osteoarthritis. It would therefore Seem reasonable to recommend a trial of glucosamine in patients with symptomatic osteoarthritis of the knee
Experimental and clinical pharmacology: Tumour necrosis factor alpha inhibitors for the treatment of adult rheumatoid arthritis
No full text
Tumour necrosis factor alpha inhibitors for the treatment of adult rheumatoid arthritis
No full textThe management of patients with rheumatoid arthritis now focuses on both the relief of symptoms and the prevention of joint damage. When conventional therapies fail, adalimumab, etanercept and infliximab, inhibitors of the pro-inflammatory cytokine tumour necrosis factor alpha, can be considered. Evidence from randomised controlled studies suggests that many patients who do not respond to conventional therapy improve with adalimumab, etanercept or infliximab, particularly when these drugs are combined with methotrexate. Infusion and injection site reactions occur in some patients and the risks of infection are increased, particularly early in the treatment course. Long-term risks such as an increased risk of malignancy are currently being evaluated
Considerations for the safe prescribing and use of COX-2-specific inhibitors
No full text© 2002 The Medical Journal of AustraliaThe majority of the "Australian COX-2-Specific Inhibitor (CSI) Prescribing Group" endorse the following points: CSIs are equivalent to non-steroidal anti-inflammatory drugs (NSAIDs) as anti-inflammatory agents. CSIs and NSAIDs modify symptoms but do not alter the course of musculoskeletal disease. CSIs do not eliminate the occurrence of ulcers or their serious complications, but are associated with considerably fewer peptic ulcers, slightly fewer upper GI symptoms and, according to published reports, fewer serious upper GI complications, notably bleeding, than CSIs and NSAIDs have similar effects on renal function and blood pressure. Whether any CSI poses a risk to cardiovascular safety remains subject to debate. Comorbidities and coprescribed drugs must be considered before initiating CSI (or NSAID) therapy. Patients prescribed CSIs (or NSAIDs) should be reviewed within the first few weeks of therapy to assess effectiveness, identify adverse effects and determine the need for ongoing therapy.David R Barraclough, James V Bertouch, Peter Brooks, Mark A Brown, Leslie G Cleland, Laurie E Clemens, Steven J Crowley, Richard O Day, Julien P DeJager, John P Edmonds, Peter J Fletcher, Gary R Franks, David C Harris, John D Horowitz, Michael D Johnston, Stephen J Kerr, Geoff O Littlejohn, Graham J MacDonald, Geoff J McColl, Phillip N Sambrook, Sepehr Shakib, Murray W Verso and Neville D Yeoman
The actual and imagined customer experiences of blood donation: a customer value perspective
No full text<b>Blood donation as an altruistic service</b>\ud
\ud
Altruistic services are increasing; there is significant growth in the number of social enterprises and commercial organisations are increasingly committed to becoming transformative in nature as they seek to improve the lives of others. One such altruistic service is blood donation, which is an essential service underpinning effective health programs in any country. Typically, blood donors are volunteers and therefore a sustainable blood supply is reliant on the goodwill and altruistic commitment of donors. In Australia, as in many other developed nations, there are considerable challenges to maintaining a sufficient and sustainable blood supply (Caulfield, 2013). From a marketing perspective, blood donation is a unique context. First, it is a ‘people-processing’ service (Lovelock, 1983, Russell-Bennett et al., 2013) where the marketing exchange relates to bodily fluid rather than to money. Second, blood donation is an altruistic social service in that it has no direct benefit for the customer donor, and only benefits other people and society as a whole (Kotler and Zaltman, 1971). Prior research has identified the customer experience as an important motivator or deterrent of this donation behaviour (Russell-Bennett, Hartel, Previte and Russell 2012; Russell-Bennett, Previte, Gallegos, Hartel, Smith and Hamilton 2013) and thus understanding the nature of the value derived from the altruistic experience is an important contribution to the value literature. Typically service researchers have investigated the value as perceived by current customers; in extending this scholarship the current study investigates the imagined value of potential customers and in an altruistic service context. In an altruistic service, the donor is an operant resource or is an interactive agent (McColl-Kennedy et al., 2012) providing skills and abilities (and body parts) for the organization to deliver its service (blood supplies to medical institutions). Considering the important resources that blood donors bring to the service experience, we respond to the call for more research on the broadened role of customers in the customer experience by McColl-Kennedy and colleagues (2015). We argue that services scholars require deeper understanding of both the actual and imagined value a service contributes to knowledge about customer value..
- …
